Lepu Medical Technology (Beijing) Co., Ltd. / Fundamentals
Income statement
- Net revenue
€722.75M - Cost of goods sold
€283.65M - Gross profit
€439.10M - SG&A expenses
€260.19M - R&D expenses
€96.18M - EBITDA
€54.92M - D&A
€2.42M - EBIT
€34.67M - Interest expenses
€21.70M - EBT
€30.80M - Tax expenses
€6.21M - Net income
€28.63M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€98.40M - Changes in working capital
€0.00 - Operating cash flow
€110.95M - Capex
€70.16M - Other investing cash flow
€26.26M - Net investing cash flow
-€67.12M - Total cash dividends paid
-€76.34M - Issuance of common stock
€0.00 - Debt repayment
€14.91M - Other financing cash flow
-€9.62M - Net financing cash flow
-€71.05M - Foreign exchange effects
€794.71K - Net change in cash
€6.85M - Cash at end of period
€418.56M - Free cash flow
€181.10M
Balance sheet
- Cash and cash equivalents
€428.29M - Cash and short-term investments
€452.65M - Total receivables
€284.43M - Inventory
€240.47M - Other current assets
€119.89M - Total current assets
€1.10B - Property, plant & equipment
€563.93M - Goodwill
€430.70M - Intangible assets
€367.27M - Long-term investments
€444.21M - Other non-current assets
€76.32M - Total non-current assets
€1.92B - Total assets
€3.02B - Accounts payable
€96.89M - Short-term debt
€39.82M - Other current liabilities
€458.24M - Total current liabilities
€611.97M - Long-term debt
€296.22M - Deferred tax liabilities
€23.70M - Other non-current liabilities
€0.00 - Total non-current liabilities
€335.07M - Total liabilities
€947.04M - Common stock
€223.76M - Retained earnings
€1.18B - Other equity
€218.17M - Total equity
€2.07B - Total liabilities and shareholders' equity
€3.02B
Company information
- Market capitalization
€3.02B - Employees
8.8K - Enterprise Value
€23.44B
Company ratios
- Gross margin
-
60.8% Better than peer group: 45.8% - EBITDA margin
-
7.6% Worse than peer group: 25.7% - EBIT margin
-
4.8% Worse than peer group: 23.0% - EBT margin
-
4.3% Worse than peer group: 23.7% - Net margin
-
4.0% Worse than peer group: 19.5% - ROE
-
1.4% Worse than peer group: 17.2% - ROA
-
0.9% Worse than peer group: 11.1% - Asset turnover
-
24.0% Much worse than peer group: 81.6% - FCF margin
-
5.6% Even with peer group: 4.2% - FCF yield
1.3% - Efficiency ratio
92.4% - Net sales per employee
-
€82.02K - Net income per employee
-
€3.25K